Navigation Links
Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
Date:6/15/2012

BOSTON (June 13, 2012)We've all seen them in the waiting room of the doctor's officepens, notepads, magnets, and clipboards adorned with the logos of brand-name drugs. These freebies may seem inconsequential, but a large and compelling body of evidence shows that even these small gifts may influence which drug a doctor prescribes.

"What most people haven't seen is many of the other giveaways that pharmaceutical and medical-device companies routinely provide to doctors, ranging from elaborate meals in local restaurants to expensive resort travel in the form of continuing medical education. Some companies spend more money on advertising their products than on research and development on new products, and prescribing physicians are their most promising target for promotional activities," said Marcia Boumil, MA, MS, JD, LLM, associate professor in the department of public health and community medicine and assistant dean, conflict of interest administration, at Tufts University School of Medicine.

As a result, many states have enacted laws limiting marketing practices by pharmaceutical companies, but are these laws constitutional? In an article, published in the current issue of the Journal of Health & Biomedical Law, Boumil examines whether these laws may violate the First Amendment in light of a recent Supreme Court precedent (Sorrell v. IMS Health, Inc.).

"These pharmaceutical gift laws are controversial but work to protect patients and lower healthcare costs by creating an environment in which doctors can make treatment decisions without undue influence," said Boumil. "Despite the intent and value of these laws, courts might now find they violate the First Amendment because the states might not be able to prove that the laws serve a clear and compelling state interest."

Sorrell v. IMS Health, Inc. was a 2011 decision by the U.S. Supreme Court that struck down a Vermont law preventing drug companies from purchasing prescriber-identified prescription data, a process known as data mining, and using it for marketing purposes, such as planning a marketing pitch to a particular physician based on the physician's prescribing habits.

The Supreme Court examined the case with a heightened level of scrutiny because the Vermont law prohibited pharmaceutical companies from using the information to enhance their marketing efforts, yet did not restrict researchers, journalists, and insurance companies from using the same information for their benefit. The Court held that a law which prohibits data mining for some purposes but not others is inherently suspect.

The Supreme Court decision determined that the law also violated First Amendment protections because Vermont had not clearly established evidence of a legitimate state interest for regulating commercial speech, although Vermont asserted that the law protected medical privacy, reduced health care costs, and safeguarded public health.

In light of the Supreme Court's willingness to apply this heightened standard of judicial scrutiny to state laws restricting commercial speech, which is endemic to state regulation, it is no longer clear that the pharmaceutical gift laws enacted in approximately 25 states would withstand a constitutional challenge, Boumil said. She noted that that the Vermont law, designed to diminish conflicts of interest in medicine, might have been more carefully crafted.

"If this same degree of scrutiny were applied to state pharmaceutical gift laws, states may be required to prove that these laws serve a clear and compelling state interest using hard datano easy task," she continued.

"The regulation of pharmaceutical giveaways and some marketing approaches, while important to minimize undue influence in the selection of drug choices, is now uncertain if a constitutional challenge is brought," Boumil added. "While the legality of state restrictions is being debated, hospitals, academic institutions, and the pharmaceutical industry itself can work to create their own policies that protect patients and minimize healthcare costs."

Boumil is also director of the Master of Public Health/Juris Doctor joint degree program at Tufts University School of Medicine and Northeastern University School of Law.


'/>"/>

Contact: Siobhan Gallagher
Siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Source:Eurekalert

Related medicine news :

1. Ohio Mail-Order Hatchery Now Linked to Salmonella in 23 States
2. States Use Only Fraction of Tobacco Revenues to Fight Smoking, Study Finds
3. Strokes More Common in Southern States: CDC
4. Injury-Linked Deaths Vary Widely Among States
5. Majority of states fail to address youth exposure to alcohol marketing
6. Belly Membrane May Regulate Immune System, Mouse Study Finds
7. Unusual protein helps regulate key cell communication pathway
8. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
9. Nobel laureate to keynote international pharmaceutical conference at URI
10. MSU invention could help pharmaceutical industry save money
11. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
Breaking Medicine Technology: